Intrinsiqs

Is AbbVie Inc. overvalued?

AbbVie Inc. (ABBV) — key valuation metrics and fundamentals.

No verdict
Price
$295.03
Fair value
—
Current P/E
—
Normal P/E
20.9
Market cap
$521.50B
Dividend yield
2.3%
Return on equity
-202.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ABBV's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 15 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonRHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.NVS Novartis AG